Europe Pharmaceutical Continuous Manufacturing Market 2020-2030 by Product (Integrated, Semi-Continuous, Controls & Software), Application (End Product, API), End User, and Country: Trend Forecast and Growth Opportunity

Europe pharmaceutical continuous manufacturing market accounted for $256.0 million in 2019 and will grow by 10.3% annually over 2020-2030 owing to the rising need for continuous manufacturing process due to cost saving and improved productivity.
Highlighted with 35 tables and 43 figures, this 115-page report “Europe Pharmaceutical Continuous Manufacturing Market 2020-2030 by Product (Integrated, Semi-Continuous, Controls & Software), Application (End Product, API), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe pharmaceutical continuous manufacturing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe pharmaceutical continuous manufacturing market in every aspect of the classification from perspectives of Product, Application, End User, and Country.

Based on Product, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Integrated Continuous Systems
Semi-Continuous Systems
• Continuous Granulators
• Continuous Blenders
• Continuous Compressors
• Continuous Coaters
• Continuous Dryers
• Other Semi-Continuous Systems
Controls & Software

Based on Application, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
End Product Manufacturing
• Solid Dosage Manufacturing
• Liquid Dosage Manufacturing
API Manufacturing

Based on End User, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Pharmaceutical Companies
• Contract Manufacturing Organizations
• Research Organizations and Institutes
• Other End Users

Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe (further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
Detailed analysis and 2019-2030 annual revenue are available for each key national market. The breakdown of key national markets by Product, Technology, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Europe pharmaceutical continuous manufacturing market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
ACG Group
Alexanderwerk
Baker Perkins Ltd.
Coperion GmbH
Fette Compacting
Freund-vector Corporation
GEA Group AG
Gebrüder Lödige Maschinenbau GmbH
Gericke AG
Glatt GmbH
Hosokawa Micron Corporation
Korsch AG
Leistritz AG
Munson Machinery Company, Inc.
Powrex Corp
Scott Equipment Company
Sturtevant, Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 28
2.4 Emerging Opportunities and Market Trends 31
2.5 Porter’s Fiver Forces Analysis 35
3 Segmentation of Europe Market by Product 41
3.1 Market Overview by Product 41
3.2 Integrated Continuous Systems 43
3.3 Semi-Continuous Systems 44
3.3.1 Continuous Granulators 46
3.3.2 Continuous Blenders 47
3.3.3 Continuous Compressors 48
3.3.4 Continuous Coaters 49
3.3.5 Continuous Dryers 50
3.3.6 Other Semi-Continuous Systems 51
3.4 Controls & Software 52
4 Segmentation of Europe Market by Application 53
4.1 Market Overview by Application 53
4.2 End Product Manufacturing 55
4.2.1 Solid Dosage Manufacturing 57
4.2.2 Liquid Dosage Manufacturing 58
4.3 API Manufacturing 59
5 Segmentation of Europe Market by End User 61
5.1 Market Overview by End User 61
5.2 Pharmaceutical Companies 63
5.3 Contract Manufacturing Organizations 64
5.4 Research Organizations and Institutes 65
5.5 Other End Users 66
6 European Market 2019-2030 by Country 67
6.1 Overview of European Market 67
6.2 Germany 70
6.3 UK 73
6.4 France 76
6.5 Spain 78
6.6 Italy 80
6.7 Russia 82
6.8 Rest of European Market 84
7 Competitive Landscape 86
7.1 Overview of Key Vendors 86
7.2 New Product Launch, Partnership, Investment, and M&A 89
7.3 Company Profiles 90
ACG Group 90
Alexanderwerk 92
Baker Perkins Ltd. 93
Coperion GmbH 94
Fette Compacting 95
Freund-vector Corporation 96
GEA Group AG 97
Gebrüder Lödige Maschinenbau GmbH 98
Gericke AG 99
Glatt GmbH 100
Hosokawa Micron Corporation 101
Korsch AG 102
Leistritz AG 103
Munson Machinery Company, Inc. 104
Powrex Corp 105
Scott Equipment Company 106
Sturtevant, Inc. 107
Thermo Fisher Scientific Inc. 108
8 Investing in Europe Market: Risk Assessment and Management 109
8.1 Risk Evaluation of Europe Market 109
8.2 Critical Success Factors (CSFs) 112
Related Reports and Products 115

Key Players (this may not be a complete list and extra companies can be added upon request):
ACG Group
Alexanderwerk
Baker Perkins Ltd.
Coperion GmbH
Fette Compacting
Freund-vector Corporation
GEA Group AG
Gebrüder Lödige Maschinenbau GmbH
Gericke AG
Glatt GmbH
Hosokawa Micron Corporation
Korsch AG
Leistritz AG
Munson Machinery Company, Inc.
Powrex Corp
Scott Equipment Company
Sturtevant, Inc.
Thermo Fisher Scientific Inc.
Table 1. Snapshot of Europe Pharmaceutical Continuous Manufacturing Market, 2019-2030 18
Table 2. Growth Rate of World Real GDP, 2017-2021 21
Table 3. Main Product Trends and Market Opportunities in Europe Pharmaceutical Continuous Manufacturing Market 31
Table 4. Europe Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn 41
Table 5. Europe Pharmaceutical Continuous Manufacturing Market: Semi-Continuous Systems by Type, 2019-2030, $ mn 45
Table 6. Europe Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn 53
Table 7. Europe Pharmaceutical Continuous Manufacturing Market: End Product Manufacturing by Type, 2019-2030, $ mn 56
Table 8. Europe Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn 61
Table 9. Europe Pharmaceutical Continuous Manufacturing Market by Country, 2019-2030, $ mn 69
Table 10. Germany Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn 72
Table 11. Germany Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn 72
Table 12. Germany Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn 72
Table 13. UK Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn 75
Table 14. UK Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn 75
Table 15. UK Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn 75
Table 16. France Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn 77
Table 17. France Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn 77
Table 18. France Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn 77
Table 19. Spain Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn 79
Table 20. Spain Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn 79
Table 21. Spain Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn 79
Table 22. Italy Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn 81
Table 23. Italy Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn 81
Table 24. Italy Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn 81
Table 25. Russia Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn 83
Table 26. Russia Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn 83
Table 27. Russia Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn 83
Table 28. Pharmaceutical Continuous Manufacturing Market in Rest of Europe by Country, 2019-2030, $ mn 85
Table 29. ACG Group: Company Snapshot 90
Table 30. ACG Group: Business Segmentation 90
Table 31. ACG Group: Product Portfolio 91
Table 32. ACG Group: Revenue, 2016-2018, $ mn 91
Table 33. ACG Group: Recent Developments 91
Table 34. Risk Evaluation for Investing in Europe Market, 2019-2030 110
Table 35. Critical Success Factors and Key Takeaways 113
Figure 1. Research Method Flow Chart 11
Figure 2. Breakdown of Primary Research 13
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 4. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 17
Figure 5. Europe Pharmaceutical Continuous Manufacturing Market, 2019-2030, $ mn 19
Figure 6. Impact of COVID-19 on Business 23
Figure 7. Primary Drivers and Impact Factors of Europe Pharmaceutical Continuous Manufacturing Market 25
Figure 8. Primary Restraints and Impact Factors of Europe Pharmaceutical Continuous Manufacturing Market 28
Figure 9. Investment Opportunity Analysis 32
Figure 10. Porter’s Fiver Forces Analysis of Europe Pharmaceutical Continuous Manufacturing Market 35
Figure 11. Breakdown of Europe Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, % of Sales Revenue 41
Figure 12. Europe Addressable Market Cap in 2020-2030 by Product, Value ($ mn) and Share (%) 42
Figure 13. Europe Pharmaceutical Continuous Manufacturing Market: Integrated Continuous Systems, 2019-2030, $ mn 43
Figure 14. Europe Pharmaceutical Continuous Manufacturing Market: Semi-Continuous Systems, 2019-2030, $ mn 44
Figure 15. Europe Pharmaceutical Continuous Manufacturing Market: Continuous Granulators, 2019-2030, $ mn 46
Figure 16. Europe Pharmaceutical Continuous Manufacturing Market: Continuous Blenders, 2019-2030, $ mn 47
Figure 17. Europe Pharmaceutical Continuous Manufacturing Market: Continuous Compressors, 2019-2030, $ mn 48
Figure 18. Europe Pharmaceutical Continuous Manufacturing Market: Continuous Coaters, 2019-2030, $ mn 49
Figure 19. Europe Pharmaceutical Continuous Manufacturing Market: Continuous Dryers, 2019-2030, $ mn 50
Figure 20. Europe Pharmaceutical Continuous Manufacturing Market: Other Semi-Continuous Systems, 2019-2030, $ mn 51
Figure 21. Europe Pharmaceutical Continuous Manufacturing Market: Controls & Software, 2019-2030, $ mn 52
Figure 22. Breakdown of Europe Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, % of Sales Revenue 54
Figure 23. Europe Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%) 54
Figure 24. Europe Pharmaceutical Continuous Manufacturing Market: End Product Manufacturing, 2019-2030, $ mn 55
Figure 25. Europe Pharmaceutical Continuous Manufacturing Market: Solid Dosage Manufacturing, 2019-2030, $ mn 57
Figure 26. Europe Pharmaceutical Continuous Manufacturing Market: Liquid Dosage Manufacturing, 2019-2030, $ mn 58
Figure 27. Europe Pharmaceutical Continuous Manufacturing Market: API Manufacturing, 2019-2030, $ mn 59
Figure 28. Breakdown of Europe Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, % of Revenue 62
Figure 29. Europe Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%) 62
Figure 30. Europe Pharmaceutical Continuous Manufacturing Market: Pharmaceutical Companies, 2019-2030, $ mn 63
Figure 31. Europe Pharmaceutical Continuous Manufacturing Market: Contract Manufacturing Organizations, 2019-2030, $ mn 64
Figure 32. Europe Pharmaceutical Continuous Manufacturing Market: Research Organizations and Institutes, 2019-2030, $ mn 65
Figure 33. Europe Pharmaceutical Continuous Manufacturing Market: Other End Users, 2019-2030, $ mn 66
Figure 34. Breakdown of European Pharmaceutical Continuous Manufacturing Market by Country, 2019 and 2030, % of Revenue 68
Figure 35. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 69
Figure 36. Pharmaceutical Continuous Manufacturing Market in Germany, 2019-2030, $ mn 71
Figure 37. Pharmaceutical Continuous Manufacturing Market in UK, 2019-2030, $ mn 73
Figure 38. Pharmaceutical Continuous Manufacturing Market in France, 2019-2030, $ mn 76
Figure 39. Pharmaceutical Continuous Manufacturing Market in Spain, 2019-2030, $ mn 78
Figure 40. Pharmaceutical Continuous Manufacturing Market in Italy, 2019-2030, $ mn 80
Figure 41. Pharmaceutical Continuous Manufacturing Market in Russia, 2019-2030, $ mn 82
Figure 42. Pharmaceutical Continuous Manufacturing Market in Rest of Europe, 2019-2030, $ mn 84
Figure 43. Growth Stage of Europe Pharmaceutical Continuous Manufacturing Industry over the Forecast Period 86

Frequently Asked Questions About This Report

Choose License Type

Each market study on Reports Globe will be revised based on COVID-19 impact analysis

How can we help you?

Our salient features

Best Solution

We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.

Customized Research

Our team of analysts and consultants provide assistance for customized research requirements

Max ROI

Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.

24/7 Support

24X7 availability to help you through the buying process as well as answer any of your doubts.

Our Clients

We've Received Your Request

We Thank You for filling out your requirements. Our sales team will get in touch with you shortly.